Drug shortage: Hydroxocobalamin Injection (HYDROXOCOBALAMIN, CYANOKIT)
FDA lists 2 presentations as Current. Availability: Unavailable (1), Limited Availability (1). Reason: Other. Companies: Teva Pharmaceuticals USA, Inc., BTG International Inc..
- Published by source
- 2024-11-04
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Products
- Hydroxocobalamin Injection HYDROXOCOBALAMIN CYANOKIT
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: mid-November 2026
- Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2024-11-04
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #894 | new | 2026-10-22 | 23bbbfcd5c35…98c102 | 1f0dc4756e95…00eeb8 |
Chain head: #1094 edf3be25ec2e…478842